Barclays raises target for Thermo Fisher Scientific stock to USD 750
Published on 10/13/2026 at 12:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS- Barclays raised its Thermo Fisher Scientific price target from USD 650 to USD 750 on October 7, 2026.
- Second-quarter revenue rose 10.00 percent to USD 11.99 billion, while adjusted earnings per share increased 13.00 percent to USD 6.03.
- Lang & Schwarz quoted the stock at EUR 595.90 on October 13, 2026 at 12:02 p.m. CEST.
- Thermo Fisher Scientific reported a USD 244.9 billion market capitalization and NYSE listing.
Thermo Fisher Scientific stock was EUR 595.90 at Lang & Schwarz on October 13, 2026 at 12:02 p.m. CEST. On October 7, 2026, Barclays raised its target from USD 650 to USD 750, according to Yahoo Finance.
Three milestones shape the stock
On July 23, 2026, Thermo Fisher reported second-quarter revenue of USD 11.99 billion, up 10.00 percent year over year, and adjusted earnings per share of USD 6.03, up 13.00 percent, in the earnings-call transcript published by Yahoo Finance. On September 21, 2026, Goldman Sachs lifted its target from USD 650 to USD 780 while maintaining a Buy rating, as reported by MarketScreener. Barclays' October 7 target revision is the latest of the three events.
What does the guidance mean for margins?
The second-quarter adjusted operating margin reached 22.80 percent, 90 basis points higher than a year earlier, while adjusted operating income increased 15.00 percent to USD 2.73 billion, according to Yahoo Finance. Management's 2026 outlook called for revenue of USD 47.4 billion to USD 48.1 billion and adjusted earnings per share of USD 24.93 to USD 25.33, with adjusted operating margin expansion of 80 basis points.
The operating figures show why analysts have continued to lift targets: adjusted earnings per share grew faster than revenue in the second quarter, while the margin expanded by 90 basis points. The counterpoint is valuation. The stock's USD 244.9 billion market capitalization and 52-week range of USD 435.27 to USD 694.33 frame a company priced near the upper end of its annual trading band in US dollars.
Results date is October 21
Thermo Fisher's next earnings date is October 21, 2026, according to Yahoo Finance. That report will show whether the stronger second-quarter margin and the raised full-year outlook carried into the next reporting period.
Price and valuation context
The NYSE-listed stock had a market capitalization of USD 244.9 billion as of October 12, 2026. The current euro quotation and the US-dollar valuation are separate venue and currency references, so the Lang & Schwarz price is not combined with the NYSE range or target figures.
The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.
Thermo Fisher Scientific stock facts
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- WKN: 857209
- Ticker: TMO
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 13, 2026, 12:02 p.m. CEST: EUR 595.90
- Market capitalization: USD 244.9 billion (as of October 12, 2026)
- 52-week range: USD 435.27-694.33 (as of October 12, 2026)
- Sector / Industry: Healthcare / Diagnostics and Research
- Index membership: S&P 500
- Next earnings date: October 21, 2026
Market context: Market report S&P 500.
